National Healthcare Agreement: PI 15–Effective management of diabetes, 2021

Identifying and definitional attributes

Metadata item type:Indicator
Indicator type:Progress measure
Short name:PI 15–Effective management of diabetes, 2021
METeOR identifier:725799
Registration status:Health, Standard 03/07/2020
Description:

Proportion of people with known diabetes who have an HbA1c (glycated haemoglobin) level less than or equal to 7.0%

Indicator set:National Healthcare Agreement (2021) Health, Standardisation pending 03/08/2020
Outcome area:Primary and Community Health Health, Standard 07/07/2010

Collection and usage attributes

Computation description:

The National Health Measures Survey component of the 2011–12 Australian Health Survey (ABS cat. no. 4364.0.55.005) included a fasting plasma glucose test and an HbA1c test. For this indicator, the fasting plasma glucose test is used in the determination of people with known diabetes and the HbA1c test is used in the determination of effective management of diabetes. Persons with known diabetes who have an HbA1c result of less than or equal to 7.0% are considered to be managing their diabetes effectively.

Known diabetes is defined as persons self-reporting that they had ever been told by a doctor or nurse that they have diabetes and:

  • they were taking diabetes medication (either insulin or tablets); or
  • their blood test result for fasting plasma glucose was greater than or equal to 7.0 mmol/L.

Excludes persons who did not fast for 8 hours or more prior to their blood test.

Reported for persons aged between 18 and 69.

Excludes women with gestational diabetes.

Analysis by remoteness and Socio-Economic Indexes for Areas (SEIFA) Index of Relative Socio-Economic Disadvantage (IRSD) is based on usual residence of the person (subject to data availability).

Presented as a percentage.

95% confidence intervals and relative standard errors calculated for rates.

Computation:

100 x (Numerator ÷ Denominator)

Numerator:

Number of persons aged between 18 and 69 with known diabetes, as determined by a fasting plasma glucose test, who have an HbA1c level of less than or equal to 7.0%.

Numerator data elements:
Data Element / Data SetData Element

Person with known diabetes as determined by a fasting plasma glucose test


Data Source
ABS Australian Health Survey (AHS), 2011–13 (2011–12 National Health Measures Survey component)
Guide for use

Data source type: Survey


Data Element / Data SetData Element

Person with known diabetes as determined by a fasting plasma glucose test


Data Source
ABS Australian Aboriginal and Torres Strait Islander Health Survey (AATSIHS), 2012–13 (National Aboriginal and Torres Strait Islander Health Measures Survey component)
Guide for use

Data source type: Survey


Data Element / Data SetData Element

Person—age


Data Source
ABS Australian Health Survey (AHS), 2011–13 (2011–12 National Health Measures Survey component)
Guide for use

Data source type: Survey


Data Element / Data SetData Element

Person—age


Data Source
ABS Australian Aboriginal and Torres Strait Islander Health Survey (AATSIHS), 2012–13 (National Aboriginal and Torres Strait Islander Health Measures Survey component)
Guide for use

Data source type: Survey


Data Element / Data SetData Element

Person—HbA1c level


Data Source
ABS Australian Health Survey (AHS), 2011–13 (2011–12 National Health Measures Survey component)
Guide for use

Data source type: Survey


Data Element / Data SetData Element

Person—HbA1c level


Data Source
ABS Australian Aboriginal and Torres Strait Islander Health Survey (AATSIHS), 2012–13 (National Aboriginal and Torres Strait Islander Health Measures Survey component)
Guide for use

Data source type: Survey


Denominator:

Number of persons aged between 18 and 69 with known diabetes, as determined by a fasting plasma glucose test.

Denominator data elements:
Data Element / Data SetData Element

Person with known diabetes as determined by a fasting plasma glucose test


Data Source
ABS Australian Health Survey (AHS), 2011–13 (2011–12 National Health Measures Survey component)
Guide for use

Data source type: Survey


Data Element / Data SetData Element

Person with known diabetes as determined by a fasting plasma glucose test


Data Source
ABS Australian Aboriginal and Torres Strait Islander Health Survey (AATSIHS), 2012–13 (National Aboriginal and Torres Strait Islander Health Measures Survey component)
Guide for use

Data source type: Survey


Data Element / Data SetData Element

Person—age


Data Source
ABS Australian Health Survey (AHS), 2011–13 (2011–12 National Health Measures Survey component)
Guide for use

Data source type: Survey


Data Element / Data SetData Element

Person—age


Data Source
ABS Australian Aboriginal and Torres Strait Islander Health Survey (AATSIHS), 2012–13 (National Aboriginal and Torres Strait Islander Health Measures Survey component)
Guide for use

Data source type: Survey


Disaggregation:

State and territory, by:

  • sex
  • Indigenous status.

Nationally, by (all not reported this cycle):

  • remoteness (Australian Statistical Geography Standard (ASGS) Remoteness Structure)
  • 2011 SEIFA IRSD
  • age (18–44, 45–54, 55–64, 65–69).

Some disaggregation may result in numbers too small for publication.

Disaggregation data elements:
Data Element / Data SetPerson—area of usual residence, statistical area level 2 (SA2) code (ASGS 2011) N(9)
Data Source
ABS Australian Health Survey (AHS), 2011–13 (2011–12 National Health Measures Survey component)
Guide for use

Data source type: Survey

Used for disaggregation by state/territory, remoteness and SEIFA


Data Element / Data SetPerson—area of usual residence, statistical area level 2 (SA2) code (ASGS 2011) N(9)
Data Source
ABS Australian Aboriginal and Torres Strait Islander Health Survey (AATSIHS), 2012–13 (National Aboriginal and Torres Strait Islander Health Measures Survey component)
Guide for use

Data source type: Survey

Used for disaggregation by state/territory


Data Element / Data SetData Element

Person—Indigenous status


Data Source
ABS Australian Health Survey (AHS), 2011–13 (2011–12 National Health Measures Survey component)
Guide for use

Data source type: Survey


Data Element / Data SetPerson—sex, code N
Data Source
ABS Australian Health Survey (AHS), 2011–13 (2011–12 National Health Measures Survey component)
Guide for use

Data source type: Survey


Data Element / Data SetData Element

Person—age


Data Source
ABS Australian Health Survey (AHS), 2011–13 (2011–12 National Health Measures Survey component)
Guide for use

Data source type: Survey


Comments:

Most recent data available for 2021 National Healthcare Agreement performance reporting: 2011–12 (total population, non-Indigenous: AHS); 2012–13 (Indigenous only: AATSIHS).

NO NEW DATA FOR 2021 REPORTING.

Representational attributes

Representation class:Percentage
Data type:Real
Unit of measure:Person
Format:

N[NN].N

Indicator conceptual framework

Framework and dimensions:Effectiveness

Data source attributes

Data sources:
Data SourceABS Australian Health Survey (AHS), 2011–13 (2011–12 National Health Measures Survey component)
Data custodian
Australian Bureau of Statistics

Data SourceABS Australian Aboriginal and Torres Strait Islander Health Survey (AATSIHS), 2012–13 (National Aboriginal and Torres Strait Islander Health Measures Survey component)
Data custodian
Australian Bureau of Statistics

Accountability attributes

Reporting requirements:

National Healthcare Agreement

Organisation responsible for providing data:

Australian Bureau of Statistics

Further data development / collection required:

Specification: Final, the measure meets the intention of the indicator.

Source and reference attributes

Reference documents:

Australian Bureau of Statistics (ABS) 2013. Australian Health Survey: Biomedical Results for Chronic Diseases, 2011–12, ABS cat. no. 4364.0.55.005. Canberra: ABS. Viewed 11 May 2020, https://www.abs.gov.au/AUSSTATS/abs@.nsf/Lookup/4364.0.55.005
main+features12011-12

Relational attributes

Related metadata references:

See also National Healthcare Agreement: PB c–Better health: reduce the age-adjusted prevalence rate for Type 2 diabetes to 2000 levels (equivalent to a national prevalence rate (for 25 years and over) of 7.1 per cent) by 2023, 2021 Health, Standard 03/07/2020

See also National Healthcare Agreement: PI 10–Prevalence of Type 2 diabetes, 2021 Health, Standard 03/07/2020

Supersedes National Healthcare Agreement: PI 15–Effective management of diabetes, 2020 Health, Standard 13/03/2020